VRCA Q4 2022 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$56M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68,000

Gross Profit

-$3M-4444.1% margin

Operating Income

-$6M-9133.8% margin

Net Income

-$6M-8723.5% margin

EPS (Diluted)

$-1.44

QoQ Revenue Growth

-99.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$45M

Total Liabilities

$5M

Stockholders' Equity

$40M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68,000	$0	—
Gross Profit	-$3M	-$200,000	-1411.0%
Operating Income	-$6M	-$8M	+26.7%
Net Income	-$6M	-$10M	+37.8%